• About us
    • Profile
    • Contributors
    • Staff
    • Address
    • Contact Us
  • Articles
    • Canada
    • USA
    • International
  • Topics
    • Access to Medicines
    • Innovation
    • Comparative Effectiveness
    • Health Technology Assessment
    • Importation
    • Global Public Health
    • Emerging Markets
    • Patient Safety
    • Patient Advocacy
  • Events
  • Publications
    • Presentations
    • Reports and Research Papers
  • Register
Home  |  Topics  |  Access to Medicines


health policy
1. Models of Public Engagement in Health Technology Assessment
2. A consumer involvement model for health technology assessment in Canada
3. Generic Drugs In Canada: A Policy Paper
4. The Importance of Patient Participation in Health Policy Decision Making
5. Treatment of rare disorders: U.S and Europe enact legislation to encourage innovation and access while Canada lags behind
6. The case for pharmacist involvement in patient health management
7. Chronic disease prevention and health promotion
8. Ontario initiative to restrict drug benefits is likely to increase overall health costs by negating the potential to improve health outcomes
9. Special Report: First Ministers Meeting, September 13-15: Timely access to care emerges as a national priority
10. Consumers and patients must have an integral role in health decision making in Canada
<< Start < Prev 1 2 Next > End >>
Powered by Tags for Joomla
 

Top Topics

  • access to medicines
  • canada
  • chronic disease
  • disease management
  • global health
  • health policy
  • health spending
  • innovation
  • usa
  • world health organization

Latest News

  • Social media is changing how epidemiologists discover and track disease outbreaks
  • CBO report: further restricting DTC advertising may be bad for public health
  • UN hosts interactive hearing on NCDs
  • Social media can greatly enhance the effectiveness of traditional marketing
  • 64th World Health Assembly – resolutions and highlights

Popular Articles

  • Chronic Disease highlighted at World Economic Forum 2011
  • Pharmacy reform in Ontario to address overpriced generic medicines
  • Global partnerships facilitate access to medicines
  • Treatment of rare disorders: U.S and Europe enact legislation to encourage innovation and access while Canada lags behind
  • Accessing Drugs for Rare Diseases in Canada: The Patient Perspective
 

Social Media

Follow whadvocacy on Twitter

linkedin_badge

facebook_badge

Login




  • Forgot your password?
  • Forgot your username?
  • Create an account

Who's Online

We have 142 guests online

Latest Events

No events
copyright © World Health Advocacy Inc.